Gut implant shows promise for diabetes and obesity control
Disease control
Not yet recruiting
This study tests a new device called the Trans-Duodenal Barrier, a temporary implant placed in the upper small intestine for 6 months. It aims to lower blood sugar (HbA1c) and help with weight loss in adults with type 2 diabetes and obesity. Researchers will also check if it impr…
Phase: NA • Sponsor: Trans-Duodenal Concepts GmbH • Aim: Disease control
Last updated May 13, 2026 16:02 UTC